2BBBullish & Bearish
ICON PLC (ICLR) trades on NASDAQ. It operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry. Its current 2BB score is 44 out of 100.
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress. As of December 2025 Icon had approximately 40,100 employees in 55 countries.
ICON PLC’s current 2BB score is 44 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 36 | Low |
| Momentum | 62 | Improving |
| Financial strength | 52 | Normal |
| Quality | 100 | Very Strong |
| Risk | 35 | Low |
| CEO | Barry Balfe |
| Founded | 1990 |
| Employees | 40.2K |
| P/E ratio | 188.71 |
| 52-week range | $66.58 – $203.91 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-10-20 | — | 2.7293 | — | $2.05B |
| 2026-07-29 | — | 2.5651 | — | $2.05B |
| 2026-06-23 | 2.5 | 2.4667 | $2.03B | $2.03B |
| 2026-05-27 | 2.52 | 3.184 | $2.11B | $2.02B |